Risk factors for Clostridium difficile infection in cirrhotic patients. 2019

Dong Yan, and Yan-Di Huang, and Yun-Bo Chen, and Tao Lv, and Si-Lan Gu, and Yong-Tao Li, and Jian-Rong Huang, and Lan-Juan Li
State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.

BACKGROUND Cirrhotic patients are susceptible to Clostridium difficile infection (CDI), however, the high risk factors are not clear. The present study aimed to identify the risk factors in cirrhotic patients with CDI. METHODS A total of 526 cirrhotic patients admitted to our hospital between May 2015 and October 2015 were included in this study. Stool samples were collected upon admission for the detection of CDI and toxin. CDI was monitored during the hospital stay. In total, 34 cases showed CDI. Then we analyzed the effects of age, sex, C. difficile colonization (CDC), multiple hospitalization, extended hospital stay, elevation of total bilirubin (TBIL), creatinine (Cr), Child-Pugh grade C, hepatic encephalopathy, hepatorenal syndrome, upper gastrointestinal hemorrhage, and exposure of antibiotics and proton pump inhibitor (PPI) on the CDI in cirrhotic patients. RESULTS Patients in the CDI group had more frequent CDC, multiple hospitalization, and extended hospital stay compared to those in the non-C. difficile infection (NCDI) group. Patients in the CDI group had higher TBIL and Cr, and higher frequency of Child-Pugh grade C, hepatic encephalopathy, upper gastrointestinal hemorrhage compared with those in the NCDI group. Multiple logistic regression analysis indicated that age >60 years (OR=1.689; 95% CI: 1.135-3.128), multiple hospitalization (OR=3.346; 95% CI: 1.392-8.043), length of hospital stay >20 days (OR=1.564; 95% CI: 1.113-2.563), hypoproteinemia (OR=4.962; 95% CI: 2.053-11.996), CDC (OR=18.410; 95% CI: 6.898-49.136), hepatic encephalopathy (OR=1.357; 95% CI: 1.154-2.368), and exposure of antibiotics (OR=1.865; 95% CI: 1.213-2.863) and PPI (OR=3.125; 95% CI: 1.818-7.548) were risk factors of CDI. CONCLUSIONS Age >60 years, multiple hospitalization, length of hospital stay >20 days, hypoproteinemia, CDC, hepatic encephalopathy, and exposure of antibiotics and PPI were risk factors for CDI in cirrhotic patients. These may contribute to the early diagnosis and monitoring of CDI in clinical practice.

UI MeSH Term Description Entries
D007902 Length of Stay The period of confinement of a patient to a hospital or other health facility. Hospital Stay,Hospital Stays,Stay Length,Stay Lengths,Stay, Hospital,Stays, Hospital
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010343 Patient Admission The process of accepting patients. The concept includes patients accepted for medical and nursing care in a hospital or other health care institution. Voluntary Admission,Admission, Patient,Admission, Voluntary,Admissions, Patient,Admissions, Voluntary,Patient Admissions,Voluntary Admissions
D010359 Patient Readmission Subsequent admissions of a patient to a hospital or other health care institution for treatment. Hospital Readmission,Rehospitalization,Unplanned Hospital Readmissions,Unplanned Readmission,30 Day Readmission,Hospital Readmissions,Readmission, Hospital,Readmissions, Hospital,Thirty Day Readmission,30 Day Readmissions,Hospital Readmission, Unplanned,Hospital Readmissions, Unplanned,Readmission, Patient,Readmission, Thirty Day,Readmission, Unplanned,Rehospitalizations,Thirty Day Readmissions,Unplanned Hospital Readmission,Unplanned Readmissions
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D003015 Clostridium Infections Infections with bacteria of the genus CLOSTRIDIUM and closely related CLOSTRIDIOIDES species. Clostridioides Infections,Clostridioides difficile Infection,Clostridioides perfringens Food Poisoning,Clostridioides perfringens Infections,Clostridioides sordellii Infection,Clostridium difficile Infections,Clostridium sordellii Infections,Clostridium difficile Infection,Clostridium perfringens Food Poisoning,Clostridium perfringens Infections,Clostridium sordellii Infection,Infections, Clostridium,Clostridioides Infection,Clostridioides perfringens Infection,Clostridium Infection,Clostridium perfringens Infection,Infection, Clostridioides difficile,Infection, Clostridioides sordellii,Infection, Clostridium,Infection, Clostridium difficile,Infection, Clostridium sordellii
D005260 Female Females
D006501 Hepatic Encephalopathy A syndrome characterized by central nervous system dysfunction in association with LIVER FAILURE, including portal-systemic shunts. Clinical features include lethargy and CONFUSION (frequently progressing to COMA); ASTERIXIS; NYSTAGMUS, PATHOLOGIC; brisk oculovestibular reflexes; decorticate and decerebrate posturing; MUSCLE SPASTICITY; and bilateral extensor plantar reflexes (see REFLEX, BABINSKI). ELECTROENCEPHALOGRAPHY may demonstrate triphasic waves. (From Adams et al., Principles of Neurology, 6th ed, pp1117-20; Plum & Posner, Diagnosis of Stupor and Coma, 3rd ed, p222-5) Encephalopathy, Hepatic,Portosystemic Encephalopathy,Encephalopathy, Hepatocerebral,Encephalopathy, Portal-Systemic,Encephalopathy, Portosystemic,Fulminant Hepatic Failure with Cerebral Edema,Hepatic Coma,Hepatic Stupor,Hepatocerebral Encephalopathy,Portal-Systemic Encephalopathy,Coma, Hepatic,Comas, Hepatic,Encephalopathies, Hepatic,Encephalopathies, Hepatocerebral,Encephalopathies, Portal-Systemic,Encephalopathies, Portosystemic,Encephalopathy, Portal Systemic,Hepatic Comas,Hepatic Encephalopathies,Hepatic Stupors,Hepatocerebral Encephalopathies,Portal Systemic Encephalopathy,Portal-Systemic Encephalopathies,Portosystemic Encephalopathies,Stupor, Hepatic,Stupors, Hepatic

Related Publications

Dong Yan, and Yan-Di Huang, and Yun-Bo Chen, and Tao Lv, and Si-Lan Gu, and Yong-Tao Li, and Jian-Rong Huang, and Lan-Juan Li
September 1998, The Journal of hospital infection,
Dong Yan, and Yan-Di Huang, and Yun-Bo Chen, and Tao Lv, and Si-Lan Gu, and Yong-Tao Li, and Jian-Rong Huang, and Lan-Juan Li
January 2023, American journal of surgery,
Dong Yan, and Yan-Di Huang, and Yun-Bo Chen, and Tao Lv, and Si-Lan Gu, and Yong-Tao Li, and Jian-Rong Huang, and Lan-Juan Li
April 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Dong Yan, and Yan-Di Huang, and Yun-Bo Chen, and Tao Lv, and Si-Lan Gu, and Yong-Tao Li, and Jian-Rong Huang, and Lan-Juan Li
January 2016, SAGE open medicine,
Dong Yan, and Yan-Di Huang, and Yun-Bo Chen, and Tao Lv, and Si-Lan Gu, and Yong-Tao Li, and Jian-Rong Huang, and Lan-Juan Li
March 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Dong Yan, and Yan-Di Huang, and Yun-Bo Chen, and Tao Lv, and Si-Lan Gu, and Yong-Tao Li, and Jian-Rong Huang, and Lan-Juan Li
March 2013, American journal of surgery,
Dong Yan, and Yan-Di Huang, and Yun-Bo Chen, and Tao Lv, and Si-Lan Gu, and Yong-Tao Li, and Jian-Rong Huang, and Lan-Juan Li
January 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Dong Yan, and Yan-Di Huang, and Yun-Bo Chen, and Tao Lv, and Si-Lan Gu, and Yong-Tao Li, and Jian-Rong Huang, and Lan-Juan Li
March 2016, Journal of gastrointestinal and liver diseases : JGLD,
Dong Yan, and Yan-Di Huang, and Yun-Bo Chen, and Tao Lv, and Si-Lan Gu, and Yong-Tao Li, and Jian-Rong Huang, and Lan-Juan Li
December 2015, Journal of gastrointestinal and liver diseases : JGLD,
Dong Yan, and Yan-Di Huang, and Yun-Bo Chen, and Tao Lv, and Si-Lan Gu, and Yong-Tao Li, and Jian-Rong Huang, and Lan-Juan Li
January 2020, Frontiers in public health,
Copied contents to your clipboard!